SBFM
Sunshine Biopharma IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.41M
P/E Ratio
—
EPS
$-1.25
Beta
1.49
52W High
$2.43
52W Low
$0.28
50-Day MA
$0.94
200-Day MA
$1.31
Dividend Yield
—
Profit Margin
-17.00%
Forward P/E
—
PEG Ratio
0.00
About Sunshine Biopharma Inc
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
Fundamentals
| Revenue (TTM) | $35.49M |
| Gross Profit (TTM) | $11.71M |
| EBITDA | $-4.23M |
| Operating Margin | -17.20% |
| Return on Equity | -27.30% |
| Return on Assets | -10.00% |
| Revenue/Share (TTM) | $7.54 |
| Book Value | $4.69 |
| Price-to-Book | 0.11 |
| Price-to-Sales (TTM) | 0.07 |
| EV/Revenue | 39.48 |
| EV/EBITDA | -7.73 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -9.10% |
| Shares Outstanding | $5.01M |
| Float | $4.90M |
| % Insiders | 0.63% |
| % Institutions | 1.64% |
Historical Volatility
HV 10-Day
63.54%
HV 20-Day
47.84%
HV 30-Day
65.88%
HV 60-Day
54.18%
HV Rank
66.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.60 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026